Counterfeit Rybelsus Semaglutide Tablets Detected
Counterfeit Rybelsus Semaglutide Tablets Recall Counterfeit Rybelsus semaglutide tablets have been detected and stopped at the Australian border. These fake tablets may pose a serious health risk and should not be used. The counterfeit products have been distributed or may be circulating across Australia.
- Product
- Consumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.
- Reason
- Consumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.
- Classification
- Class II
- Category
- drug recall
- Country
- Australia
- Agency
- Therapeutic Goods Administration
- Recall date
- 2025-06-24
- Status
- Ongoing
- Distribution
- Australia-wide
Official recall notice from Therapeutic Goods Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/d5f7e10a-807c-49b5-aa18-346c2e0129a7